| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Salt-form |
| UNII | 3U9A0FE9N5 |
| Parent Compound: | DOXEPIN |
| InChI Key | MHNSPTUQQIYJOT-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H22ClNO |
| Molecular Weight | 315.84 |
| AlogP | 3.96 |
| Hydrogen Bond Acceptor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 12.47 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 21.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Norepinephrine transporter inhibitor | INHIBITOR | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 101.82 |
|
Protein: Norepinephrine transporter Description: Sodium-dependent noradrenaline transporter Organism : Homo sapiens P23975 ENSG00000103546 |
||||
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1628234 |
| FDA SRS | 3U9A0FE9N5 |
| SureChEMBL | SCHEMBL41532 |